Highest Price Target1
Lowest Price Target1
Consensus Price Target1
Analyst Rating Summary1
Analyst Firms Making Recommendations1
- Goldman Sachs
- JP Morgan
- RBC Capital
1calculated from analyst ratings published within the last 6 months
Analyst Ratings for Sotera Health
What is the target price for Sotera Health (SHC)?
The latest price target for Sotera Health (NASDAQ: SHC) was reported by Goldman Sachs on November 23, 2022. The analyst firm set a price target for $8.00 expecting SHC to fall to within 12 months (a possible -10.51% downside). 18 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Sotera Health (SHC)?
The latest analyst rating for Sotera Health (NASDAQ: SHC) was provided by Goldman Sachs, and Sotera Health maintained their neutral rating.
When is the next analyst rating going to be posted or updated for Sotera Health (SHC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sotera Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sotera Health was filed on November 23, 2022 so you should expect the next rating to be made available sometime around November 23, 2023.
Is the Analyst Rating Sotera Health (SHC) correct?
While ratings are subjective and will change, the latest Sotera Health (SHC) rating was a maintained with a price target of $9.00 to $8.00. The current price Sotera Health (SHC) is trading at is $8.94, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.